ICM
HCAT icon

Invenomic Capital Management’s Health Catalyst HCAT Stock Holding History

Invenomic Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-850,581
Closed -$5.44M – 162
2024
Q2 		$5.44M Buy
+850,581
New +$5.46M 0.26% 102

Other funds holding HCAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Invenomic Capital Management's HCAT Position: Q3 2024 in Review

Invenomic Capital Management sold out of Health Catalyst (HCAT) in Q3 2024, closing a stake of 850,581 shares — an estimated $5.44M sold.

Invenomic Capital Management first reported a position in HCAT in Q2 2024 and held it in 1 quarter. The position peaked at $5.44M in Q2 2024. 159 funds tracked by Wall St. Rank hold HCAT as of Q3 2024.

  • Invenomic Capital Management reported no remaining Health Catalyst position as of Q3 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 850,581 Health Catalyst shares in Q3 2024, an estimated $5.44M.
  • Invenomic Capital Management first reported a position in Health Catalyst in Q2 2024 and held it in 1 quarter.
  • Invenomic Capital Management's Health Catalyst position peaked at $5.44M in Q2 2024.
  • 159 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2024.

Based on Invenomic Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.